BioScrip amends credit agreement

BioScrip Inc. (Nasdaq: BIOS) expects fourth quarter results to be at the high end of its guidance and announced a proposed Amendment to its Credit Agreement. The stock price soared 36 cents to close at $1.40.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.